Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.100 |
None |
1.000 |
37 |
|
1995 |
2020 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.100 |
None |
0.900 |
30 |
|
1992 |
2020 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.100 |
None |
0.893 |
28 |
|
2013 |
2020 |
Familial lichen amyloidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
230
|
24
|
0.100 |
None |
0.963 |
27 |
1
|
1996 |
2020 |
Prostate cancer recurrent
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
54
|
|
0.100 |
None |
0.963 |
27 |
|
2003 |
2020 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.100 |
None |
0.944 |
18 |
1
|
2001 |
2020 |
Prostatic Diseases
|
group |
Male Urogenital Diseases
|
Disease or Syndrome
|
72
|
4
|
0.100 |
None |
0.889 |
18 |
|
1994 |
2020 |
Lower Urinary Tract Symptoms
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
77
|
30
|
0.100 |
None |
1.000 |
17 |
|
2001 |
2019 |
Salivary Gland Pleomorphic Adenoma
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
63
|
9
|
0.100 |
None |
0.938 |
16 |
|
1994 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.100 |
None |
1.000 |
15 |
|
1998 |
2020 |
Non-metastatic prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
18
|
|
0.100 |
None |
1.000 |
13 |
|
2017 |
2020 |
Adenocarcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2235
|
168
|
0.100 |
None |
0.846 |
13 |
|
1990 |
2020 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.100 |
None |
1.000 |
12 |
|
1995 |
2011 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.100 |
None |
1.000 |
11 |
|
2017 |
2020 |
prostatitis
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
86
|
1
|
0.100 |
None |
0.909 |
11 |
|
2000 |
2019 |
Anxiety Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
840
|
163
|
0.100 |
None |
0.900 |
10 |
|
2002 |
2018 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.100 |
None |
0.900 |
10 |
|
2017 |
2020 |
Prostate specific antigen measurement
|
phenotype |
|
Laboratory Procedure
|
25
|
95
|
0.100 |
None |
1.000 |
3 |
3
|
2010 |
2017 |
Autoimmune Diseases
|
group |
Immune System Diseases
|
Disease or Syndrome
|
1758
|
428
|
0.090 |
None |
0.889 |
9 |
|
2002 |
2019 |
Anxiety
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1048
|
287
|
0.090 |
None |
0.889 |
9 |
|
2002 |
2018 |
Recurrent tumor
|
phenotype |
|
Neoplastic Process
|
735
|
33
|
0.090 |
None |
0.556 |
9 |
|
1995 |
2019 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.090 |
None |
1.000 |
9 |
|
2009 |
2019 |
androgen independent prostate cancer
|
disease |
|
Neoplastic Process
|
190
|
5
|
0.070 |
None |
0.857 |
7 |
|
2001 |
2017 |
Carcinoma of bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2104
|
309
|
0.070 |
None |
1.000 |
7 |
|
2001 |
2019 |
Prostate cancer, familial
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
116
|
25
|
0.070 |
None |
1.000 |
7 |
|
1998 |
2017 |